| 8.71 0.05 (0.58%) | 02-20 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 12.08 | 1-year : | 13.63 |
| Resists | First : | 10.34 | Second : | 11.67 |
| Pivot price | 9.74  |
|||
| Supports | First : | 8.2 | Second : | 6.82 |
| MAs | MA(5) : | 8.56 |
MA(20) : | 9.98 |
| MA(100) : | 10.32 |
MA(250) : | 9.2 |
|
| MACD | MACD : | -0.5 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 15.5 |
D(3) : | 13.3 |
| RSI | RSI(14): 34.5 |
|||
| 52-week | High : | 14.53 | Low : | 5.22 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ NUS ] has closed above bottom band by 20.1%. Bollinger Bands are 115.7% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 4 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 8.76 - 8.8 | 8.8 - 8.83 |
| Low: | 8.4 - 8.44 | 8.44 - 8.48 |
| Close: | 8.65 - 8.71 | 8.71 - 8.77 |
Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, LifePak nutritional supplements, ageLOC Meta nutritional supplements, and Beauty Focus Collagen+ skin care supplements, as well as other weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Thu, 19 Feb 2026
Nu Skin Still Has Long-Term Turnaround Potential (NYSE:NUS) - Seeking Alpha
Mon, 16 Feb 2026
Short Interest in Nu Skin Enterprises, Inc. (NYSE:NUS) Drops By 16.0% - MarketBeat
Mon, 16 Feb 2026
Should You Sell Your Stake in Nu Skin Enterprises (NUS)? - Yahoo Finance
Fri, 13 Feb 2026
Nu Skin Enterprises Q4 Earnings Lag Estimates, Revenues Down Y/Y - TradingView
Fri, 13 Feb 2026
Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 2025 Q4 - Yahoo Finance
Fri, 13 Feb 2026
Nu Skin Enterprises, Inc. (NYSE:NUS) Declares Quarterly Dividend of $0.06 - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NYSE
|
|
|
Sector:
Consumer Defensive
|
|
|
Industry:
Household & Personal Products
|
|
| Shares Out | 49 (M) |
| Shares Float | 48 (M) |
| Held by Insiders | 2.1 (%) |
| Held by Institutions | 78.1 (%) |
| Shares Short | 2,090 (K) |
| Shares Short P.Month | 2,300 (K) |
| EPS | 2.18 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 16.29 |
| Profit Margin | 7 % |
| Operating Margin | 5.9 % |
| Return on Assets (ttm) | 4.1 % |
| Return on Equity (ttm) | 14.5 % |
| Qtrly Rev. Growth | -15.4 % |
| Gross Profit (p.s.) | 22.35 |
| Sales Per Share | 32 |
| EBITDA (p.s.) | 3.18 |
| Qtrly Earnings Growth | 103.5 % |
| Operating Cash Flow | 89 (M) |
| Levered Free Cash Flow | 165 (M) |
| PE Ratio | 3.99 |
| PEG Ratio | 0 |
| Price to Book value | 0.53 |
| Price to Sales | 0.27 |
| Price to Cash Flow | 4.74 |
| Dividend | 0.05 |
| Forward Dividend | 0 |
| Dividend Yield | 0.6% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|